DK3206686T3 - Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker - Google Patents

Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker Download PDF

Info

Publication number
DK3206686T3
DK3206686T3 DK15833863.2T DK15833863T DK3206686T3 DK 3206686 T3 DK3206686 T3 DK 3206686T3 DK 15833863 T DK15833863 T DK 15833863T DK 3206686 T3 DK3206686 T3 DK 3206686T3
Authority
DK
Denmark
Prior art keywords
diketones
wrinkles
gamma
aging
prevention
Prior art date
Application number
DK15833863.2T
Other languages
English (en)
Inventor
John Hood
Sunil Kumar Kc
Osman Kibar
Original Assignee
Samumed Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samumed Llc filed Critical Samumed Llc
Application granted granted Critical
Publication of DK3206686T3 publication Critical patent/DK3206686T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK15833863.2T 2014-08-20 2015-08-20 Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker DK3206686T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462039786P 2014-08-20 2014-08-20
PCT/US2015/046120 WO2016029021A1 (en) 2014-08-20 2015-08-20 Gamma-diketones for treatment and prevention of aging skin and wrinkles

Publications (1)

Publication Number Publication Date
DK3206686T3 true DK3206686T3 (da) 2019-12-16

Family

ID=55351257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15833863.2T DK3206686T3 (da) 2014-08-20 2015-08-20 Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker

Country Status (26)

Country Link
US (4) US9795550B2 (da)
EP (1) EP3206686B1 (da)
JP (1) JP6766047B2 (da)
KR (1) KR102165385B1 (da)
CN (1) CN107106549B (da)
AU (1) AU2015305373B2 (da)
BR (1) BR112017003959B1 (da)
CA (1) CA2958580C (da)
CL (1) CL2017000410A1 (da)
CY (1) CY1122603T1 (da)
DK (1) DK3206686T3 (da)
ES (1) ES2762559T3 (da)
HR (1) HRP20192161T1 (da)
HU (1) HUE046741T2 (da)
IL (1) IL250663B (da)
LT (1) LT3206686T (da)
MA (1) MA40454B1 (da)
MX (1) MX368248B (da)
PL (1) PL3206686T3 (da)
PT (1) PT3206686T (da)
RS (1) RS59797B1 (da)
RU (1) RU2727039C2 (da)
SI (1) SI3206686T1 (da)
SM (1) SMT201900709T1 (da)
WO (1) WO2016029021A1 (da)
ZA (1) ZA201701460B (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3915367A1 (en) 2010-08-18 2021-12-01 BioSplice Therapeutics, Inc. Diketones and hydroxyketones as catenin signaling pathway activators
PE20151721A1 (es) 2013-02-22 2015-12-07 Samumed Llc Y-dicetonas como activadores de la ruta de senalizacion de wnt/b-catenina
DK3206686T3 (da) 2014-08-20 2019-12-16 Samumed Llc Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
CN105708748B (zh) * 2014-12-04 2020-06-30 玫琳凯有限公司 化妆品组合物
AU2016302401B2 (en) * 2015-08-04 2021-11-25 Eupharma Pty Ltd Emollient composition
MX382934B (es) * 2015-12-24 2025-03-13 Unilever Ip Holdings B V Inhibidores de tirosinasa.
US20170296460A1 (en) * 2016-04-14 2017-10-19 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US10463601B1 (en) * 2016-06-17 2019-11-05 Lorita Dillon Topical cosmetic composition
WO2018081005A1 (en) * 2016-10-25 2018-05-03 Access Business Group International Llc Compositions of lithospermum erythrorhizon (gromwell root) and methods of making and using the compositions
AU2017386417B2 (en) 2016-12-30 2022-07-14 Frequency Therapeutics, Inc. 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells
CN110769841A (zh) * 2017-06-13 2020-02-07 玫琳凯有限公司 化妆品组合物及其用于使皮肤紧致的方法
US11318179B2 (en) 2017-06-20 2022-05-03 Jessica Kado Topical formulation for binding to dermatological cannabinoid receptors
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
KR102843430B1 (ko) * 2018-05-14 2025-08-08 켄부 브랜드 엘엘씨 보습 크림 및 로션
CN108813246A (zh) * 2018-05-31 2018-11-16 陕西顾森健康科技有限公司 一种易吸收防流失的胶原蛋白肽抗衰组合物及其制备工艺
US10980851B2 (en) * 2018-06-08 2021-04-20 The Procter & Gamble Company Topical skincare compositions comprising Centella asiatica selected triterpenes
WO2020037326A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo
WO2020037323A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by upregulating jag-1
KR101938877B1 (ko) * 2018-08-20 2019-01-16 안디바 주식회사 수딩크림 조성물 및 그의 제조방법
CN109394570A (zh) * 2018-11-08 2019-03-01 杭州百芮生物科技有限公司 一种超分子水杨酸复合凝胶及其制备方法
KR102021014B1 (ko) * 2018-11-21 2019-09-16 신민지 가슴 크림 제조방법 및 이에 의해 제조된 가슴 크림
DE102018131724A1 (de) * 2018-12-11 2020-06-18 Wellstar Gmbh & Co. Kg Zusammensetzung und Verwendung der Zusammensetzung als Anti-Aging-Mittel
KR101987099B1 (ko) * 2018-12-19 2019-06-10 주식회사 메디셀 피부온도 감응형 기능성 하이드로겔 조성물을 이용한 팔뚝 붓기완화용 패치 및 그 제조방법
KR102031885B1 (ko) * 2019-01-08 2019-10-15 안디바 주식회사 마카 추출물을 함유한 수딩크림 조성물
CN113645985A (zh) * 2019-02-25 2021-11-12 塔普克斯制药公司 用于治疗性皮肤处理的方法、组合物、片材
CN109820802A (zh) * 2019-04-11 2019-05-31 冯江 一种亮颜润肤精华液及其制备方法
CN109925248B (zh) * 2019-04-28 2021-10-19 青岛科技大学 一种含有根皮素、三七总皂苷抗皮肤光老化作用的护肤组合物
FR3097558B1 (fr) * 2019-06-24 2021-06-25 Oreal Méthode de diagnostic d’un vieillissement prématuré de la peau
US11633368B2 (en) 2019-09-03 2023-04-25 Milton D. Moore Enhanced moisturizing lotion compositions
CN110711161A (zh) * 2019-11-03 2020-01-21 广州悦荟化妆品有限公司 一种免洗型的舒敏修护精华面膜
KR102369744B1 (ko) * 2019-12-24 2022-03-03 경희대학교 산학협력단 부들레야 다비디 추출물을 포함하는 항염증용 조성물
US20210251852A1 (en) * 2020-02-14 2021-08-19 Tiwona Ross Aloe Mint Scalp Wipes
US20210251882A1 (en) * 2020-02-17 2021-08-19 Mary Kay Inc. Topical cosmetic compositions
WO2021188295A1 (en) * 2020-03-17 2021-09-23 Epidarus Therapeutics, Llc Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof
CN111297736A (zh) * 2020-03-18 2020-06-19 苏州工业园区黛宜菲化妆品有限公司 一种具有修护皮脂膜作用的修颜油
CN111388376B (zh) * 2020-04-20 2022-06-21 广西诗琳茉莉生物科技集团有限公司 一种茉莉草本抗敏舒缓面膜及其制备方法
US11213473B1 (en) * 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition
KR102233707B1 (ko) * 2021-01-06 2021-03-29 김현숙 천연 추출물 및 천연 가루를 포함하는 화장료 조성물
CA3206155A1 (en) * 2021-01-29 2022-08-04 ChromaDex Inc. Ethyl cellulose based coatings for microencapsulation of nicotinamide riboside and other nicotinyl riboside compounds
CN112870108A (zh) * 2021-02-07 2021-06-01 上海百雀羚生物科技有限公司 一种具有抗衰老、保湿功效的组合物及其制备方法和应用
US11642305B2 (en) 2021-06-03 2023-05-09 Melissa Kadzai Composition for a skin and hair product
CN113876641A (zh) * 2021-11-05 2022-01-04 上海新高姿化妆品有限公司 一种具有抗皱紧致功效的化妆品组合物及其应用
US11484489B1 (en) * 2021-12-08 2022-11-01 Codex Beauty Corporation Skin care compositions and methods for regulating sebum production
CN113956244B (zh) * 2021-12-21 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种用于皮肤复新的肌肽衍生物及其用途
EP4460493A4 (en) 2022-01-07 2025-12-31 Oddity Labs Llc SKIN COMPOSITIONS, FORMULATIONS AND PROCESSES
CA3252183A1 (en) * 2022-01-18 2023-07-27 IC-MedTech Corp. BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
CN114432207B (zh) * 2022-03-09 2023-06-16 上海柒色生物科技有限公司 一种长效保湿修复组合物、修复霜及其制备方法
US12194120B2 (en) 2022-05-31 2025-01-14 Heidi Skin, Llc Skin care formulation containing silver nanoparticles
CN115804736B (zh) * 2022-12-14 2024-04-26 广州臻颜化妆品有限公司 一种多效润唇膏及其制备方法
CN116712359B (zh) * 2023-03-27 2025-02-11 山东福瑞达生物股份有限公司 一种益生菌发酵复合植物提取物的制备及应用
CN116807932A (zh) * 2023-08-10 2023-09-29 羽楠(广州)化妆品有限公司 一种海洋来源的抗皱紧致组合物及其应用以及包括该组合物的精华液及其制备方法
KR102597707B1 (ko) * 2023-09-07 2023-11-03 (주)스타팜텍 얼굴 주름 개선 및 미백 효과를 가지는 기능성 화장품 조성물
KR102869831B1 (ko) * 2023-09-19 2025-10-14 주식회사 코리아나화장품 풀루란, 피브이엠/엠에이코폴리머 및 바다포도추출물을 포함하는 피부 리프팅용 화장료 조성물
CN117598924B (zh) * 2023-11-30 2024-06-18 广州市仙迪生物科技有限公司 一种植物多肽组合物及其应用
CN117653563B (zh) * 2023-12-13 2024-06-04 奥俐莱雅（广东）家化科技有限公司 一种高透皮性的重组胶原蛋白肽及其制备工艺和应用
CN117797081B (zh) * 2024-01-02 2025-10-17 诺斯贝尔化妆品股份有限公司 一种控油舒缓祛痘组合物及其制备方法和应用
WO2026018148A1 (en) * 2024-07-15 2026-01-22 Next Herbals Llc Herbal formulation for the management of metabolic disorders, and method of preparation thereof
CN119039469B (zh) * 2024-08-01 2026-04-03 华南理工大学 一种酶法提取的刺梨多糖及其制备方法与应用
PL452068A1 (pl) * 2025-05-16 2026-03-16 Vgs Polska Spółka Z Ograniczoną Odpowiedzialnością Naturalny krem do twarzy nawilżający
CN122075332A (zh) * 2026-04-24 2026-05-26 水羊化妆品制造有限公司 一种组合物、其制备方法及防晒组合物

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3040054A (en) 1960-08-03 1962-06-19 Olin Mathieson 2, 2'-(1, 4-diaminotetramethylene) bis(4-thiazolecarboxylic acid), salts and process
US3855675A (en) 1971-05-25 1974-12-24 Squibb & Sons Inc 1-(2-furanylmethyl)-1h-pyrazolo(3,4-b)pyridine-5-methanones
US4014889A (en) 1972-12-20 1977-03-29 Bayer Aktiengesellschaft Process for preparing ketones
US4032526A (en) 1975-10-02 1977-06-28 American Cyanamid Company 1,2-dimethyl-3 or 5-piperazinyl-pyrazolium salts
US4164559A (en) 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
DE2808070A1 (de) 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
US4761471A (en) 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
DE3331692A1 (de) 1983-09-02 1985-03-28 Basf Ag, 6700 Ludwigshafen 3-phenyl-4-methoxycarbonylpyrazole, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
EP0230110A1 (en) 1985-11-30 1987-07-29 FISONS plc Pharmacologically active pyrrole and pyrazole derivatives
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
WO1988003805A1 (en) 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
FR2613360B1 (fr) * 1987-04-03 1989-06-09 Oreal Nouveaux derives aromatiques d'acide butyrique, leur procede de preparation et leur utilisation en medecine humaine et veterinaire ainsi qu'en cosmetique
NZ227287A (en) 1987-12-21 1992-01-29 Merck & Co Inc 2,5-diaryl tetrahydrofurans and medicaments
AU626881B2 (en) * 1988-07-14 1992-08-13 F. Hoffmann-La Roche Ag Benzofused heterocyclics used as pharmaceuticals
IL91418A (en) 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
EP0365089A3 (en) 1988-10-18 1991-06-05 Merck & Co. Inc. 2-aryl-5(3-methoxy-5-(hydroxypropylsulfonyl)-4-propoxyphenyl) tetrahydrothiophen and analogs
ATE162223T1 (de) 1989-03-28 1998-01-15 Genetics Inst Osteoinduktive zusammensetzungen
ATE124394T1 (de) 1990-04-27 1995-07-15 Duphar Int Res Verfahren zur photochemischen isomerisierung von organischen verbindungen unter dem einfluss eines photosensibilisators.
DE4104931A1 (de) 1991-02-18 1992-08-20 Hoechst Ag Verfahren zur herstellung substituierter indene
JPH05170764A (ja) 1991-12-24 1993-07-09 Sumitomo Pharmaceut Co Ltd 新規なヒドロキシカルコン誘導体
GB9203806D0 (en) 1992-02-21 1992-04-08 Unilever Plc Sunscreen agents
DK57892D0 (da) 1992-05-01 1992-05-01 Nkt Res Center As Fremgangsmaade til fremstilling af 1,4-bis-aryl-butan-1,4-dioner og poly(arylen-butan-1,4-dioner)
US5760053A (en) 1994-10-07 1998-06-02 Meiji Seika Kabushiki Kaisha γ-Diketone compounds with inhibitory activity against platelet aggregation
AU1726695A (en) 1995-01-13 1996-07-31 Board Of Regents, The University Of Texas System Turcasarins, novel expanded porphyrins, and uses thereof
US5668148A (en) 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
US5585118A (en) 1995-06-02 1996-12-17 Brigham And Women's Hospital Choline in the treatment of bipolar disorder
US5668165A (en) 1995-06-07 1997-09-16 Scriptgen Pharmaceuticals, Inc. Small molecule inhibition of RNA/ligand binding
JP3964478B2 (ja) 1995-06-30 2007-08-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
IL125820A0 (en) 1996-02-19 1999-04-11 Japan Tobacco Inc Therapeutic agent for diabetes and a pharmaceutical composition containing the same
ATE247955T1 (de) 1996-06-03 2003-09-15 Purdue Research Foundation Selenophen-antitumormittel
US6620804B2 (en) 1996-06-03 2003-09-16 Purdue Research Foundation Selenophene anti-tumor agents
US6440102B1 (en) 1998-07-23 2002-08-27 Durect Corporation Fluid transfer and diagnostic system for treating the inner ear
WO2000009500A2 (en) 1998-08-11 2000-02-24 Nihon Bayer Agrochem K.K. Nematicidal pyrazoles
WO2000026197A1 (en) 1998-10-29 2000-05-11 Bristol-Myers Squibb Company Novel inhibitors of impdh enzyme
DE19853299C2 (de) 1998-11-19 2003-04-03 Thomas Lenarz Katheter zur Applikation von Medikamenten in Flüssigkeitsräumen des menschlichen Innenohrs
US6120484A (en) 1999-02-17 2000-09-19 Silverstein; Herbert Otological implant for delivery of medicament and method of using same
WO2001000578A1 (en) 1999-06-25 2001-01-04 Merck & Co., Inc. 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
EP1067195B1 (de) 1999-07-09 2006-09-20 Forschungszentrum Jülich Gmbh Verfahren zur Reduktion von Ketogruppen enthaltende Verbindungen
CZ304307B6 (cs) 1999-07-13 2014-02-26 Lonza Ag Způsob výroby 2-amino-4-(4-fluorfenyl)-6-alkyl-pyrimidin-5-karboxylátu
DE60019505T2 (de) 1999-08-06 2005-09-15 Ciba Speciality Chemicals Holding Inc. Mikrobizide Wirksubstanzen
AUPQ288499A0 (en) 1999-09-16 1999-10-07 Biota Scientific Management Pty Ltd Antiviral agents
EP1224189B1 (en) 1999-10-07 2006-01-25 Eli Lilly And Company Condensed dihydroquinolinone derivatives for inhibiting mrp1
US6268375B1 (en) * 1999-12-29 2001-07-31 Research Triangle Institute 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
JP2001294581A (ja) 2000-04-12 2001-10-23 Nippon Bayer Agrochem Co Ltd イソチアゾール誘導体
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
PT1300398E (pt) 2000-07-05 2006-07-31 Astellas Pharma Inc Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
DE10059749A1 (de) 2000-12-01 2002-06-20 Henkel Kgaa Fixierung von Wirkstoffen an fasrigen Materialien
DE60229114D1 (en) 2001-03-02 2008-11-13 Axys Pharm Inc Cathepsincystein-proteasehemmer
MXPA03008888A (es) * 2001-03-29 2005-03-07 Vertex Pharma Inhibidores de n-terminal c-jun cinasas (jnk) y otras proteinas cinasas.
SI1373263T1 (en) * 2001-04-05 2005-04-30 Torrent Pharmaceuticals Ltd Heterocyclic compounds for aging-related and diabetic vascular complications
EP2295550A3 (en) 2001-04-30 2011-12-14 Vertex Pharmaceuticals Incorporated Crystal structures of GSK-3beta protein and protein complexes and their use
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
WO2003016266A1 (fr) 2001-08-16 2003-02-27 Japan Tobacco Inc. Composes $g(b)-cetoamides et leur utilisation medicinale
US6648873B2 (en) 2001-09-21 2003-11-18 Durect Corp. Aural catheter system including anchor balloon and balloon inflation device
KR20050035142A (ko) 2001-10-11 2005-04-15 카네카 코포레이션 페록시좀 증식제 응답성 수용체 리간드제 및 그 제조 방법
CN1155590C (zh) 2002-04-12 2004-06-30 中国药科大学 具有抗肿瘤活性的色酮类化合物及其开环产物与制备方法
WO2004016592A1 (en) 2002-08-14 2004-02-26 Ppd Discovery, Inc. Prenylation inhibitors and methods of their synthesis and use
US20040266732A1 (en) 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
FR2849598B1 (fr) 2003-01-07 2006-09-22 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
US20040224003A1 (en) 2003-02-07 2004-11-11 Schultz Robert K. Drug formulations for coating medical devices
JP2006523707A (ja) 2003-04-15 2006-10-19 アストラゼネカ アクツィエボラーグ 治療化合物
BRPI0412684A (pt) * 2003-07-17 2006-10-03 Plexxinko Inc compostos ppar-ativos
US7008953B2 (en) 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
US20050175562A1 (en) * 2004-01-05 2005-08-11 Anke Hadasch Skin makeup composition
US20060276536A1 (en) 2004-02-12 2006-12-07 Vander Jagt David L Cancer treatment using curcumin derivatives
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
JP2007526324A (ja) 2004-03-02 2007-09-13 スミスクライン・ビーチャム・コーポレイション Ａｋｔ活性のある阻害剤
US7825278B2 (en) 2004-05-06 2010-11-02 The Regents Of The University Of California Substituted enaminones, their derivatives and uses thereof
MXPA06014131A (es) 2004-06-04 2007-03-07 Astellas Pharma Inc Derivado de propano-1,3-diona o su sal.
DE102004029309A1 (de) 2004-06-17 2005-12-29 Bayer Cropscience Gmbh Pyridinylisoxazole und ihre Verwendung als Herbizide
EP2027853A3 (en) 2004-06-18 2011-01-05 Agennix USA Inc. Kinase inhibitors for treating cancers
EP1786415A4 (en) 2004-08-16 2010-01-20 Verva Pharmaceuticals Pty METABOLISM MODULATION AGENTS AND USES THEREOF
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
FR2880802B1 (fr) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
JP2008094720A (ja) 2005-01-20 2008-04-24 Astellas Pharma Inc キノロン誘導体のプロドラッグ又はその塩
JP2008537684A (ja) 2005-01-24 2008-09-25 ニューロシステック コーポレイション 内耳およびその他の組織へ治療薬および／またはその他の薬剤を送達するための装置および方法
EP1844035A1 (en) 2005-02-01 2007-10-17 Wyeth Amino-pyridines as inhibitors of beta-secretase
SI1864976T1 (sl) 2005-03-31 2012-12-31 Astellas Pharma Inc. Propan-1,3-dionski derivat ali njegova sol
JP5050206B2 (ja) 2005-06-27 2012-10-17 国立大学法人東北大学 ビス（アリールメチリデン）アセトン化合物、抗癌剤、発癌予防剤、Ｋｉ−Ｒａｓ、ＥｒｂＢ２、ｃ−Ｍｙｃ及びＣｙｃｌｉｎＤ１の発現抑制剤、β−カテニン分解剤並びにｐ５３の発現増強剤
DE102005031580A1 (de) 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituierte Sulfolanylpyrazole und ihre Verwendung
WO2007016525A2 (en) 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
WO2007051314A1 (en) 2005-11-07 2007-05-10 American Diagnostica Inc. Curcuminoid compounds for inhibiting plasminogen activator inhibitor-1
ATE486875T1 (de) 2005-11-10 2010-11-15 Chemocentryx Inc Substituierte chinolone und verwendungsverfahren
WO2007103584A2 (en) 2006-03-09 2007-09-13 Nanovir, Llc Polyamides for treating human papilloma virus
MX2008013194A (es) 2006-04-11 2008-12-01 Vertex Pharma Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
JP2008007428A (ja) 2006-06-27 2008-01-17 Showa Denko Kk 皮膚外用シワ防止剤
WO2008020625A1 (en) 2006-08-17 2008-02-21 Kanazawa University Dibenzoylmethane compound and pharmaceutical composition comprising the compound as active ingredient
JP5324220B2 (ja) 2006-08-30 2013-10-23 株式会社ヤクルト本社 シワ形成抑制剤
US7875603B2 (en) 2006-09-21 2011-01-25 Nova Southeastern University Specific inhibitors for vascular endothelial growth factor receptors
JP5207341B2 (ja) 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
JP5231829B2 (ja) 2007-02-15 2013-07-10 石原産業株式会社 ピリジル−トリアゾロピリミジン誘導体又はその塩、それらを含有する有害生物防除剤並びにそれらの製造方法
WO2008118626A2 (en) 2007-03-08 2008-10-02 Burnham Institute For Medical Research Inhibitors of jnk and methods for identifying inhibitors of jnk
JP5309318B2 (ja) 2007-03-09 2013-10-09 国立大学法人 岡山大学 エステル、カルボン酸及びアミドの製造方法
CN101679429A (zh) 2007-04-18 2010-03-24 阿斯利康(瑞典)有限公司 5-氨基吡唑-3-基-3h-咪唑并[4,5-b]吡啶衍生物及其治疗癌的用途
KR101404398B1 (ko) 2007-06-20 2014-06-09 (주)뉴트리 주름개선 화장료 조성물
MX2010004761A (es) 2007-11-02 2010-05-19 Novartis Ag Moleculas y metodos para modular la proteina relacionada con el receptor de lipoproteina de baja densidad 6 (lrp6).
AU2008324203A1 (en) 2007-11-05 2009-05-14 Novartis Ag Methods and compositions for measuring Wnt activation and for treating Wnt-related cancers
WO2009071997A2 (en) 2007-12-06 2009-06-11 Centre National De La Recherche Scientifique (C.N.R.S.) Iron and copper catalytic systems for cross-coupling reactions
JP2009179619A (ja) 2008-02-01 2009-08-13 Toyo Ink Mfg Co Ltd 新規オキシムエステル化合物およびそれを含んでなるラジカル重合開始剤および重合性組成物
CN102099005A (zh) 2008-02-27 2011-06-15 先灵-普劳健康护理产品公司 含有阿伏苯宗的防晒组合物增强的光稳定性
EP2291349A2 (en) 2008-04-14 2011-03-09 The Board of Regents of The University of Texas System Small molecule inhibitors of the pleckstrin homology domain and methods for using same
KR101538822B1 (ko) 2008-05-08 2015-07-22 노바 사우쓰이스턴 유니버시티 혈관 내피 성장 인자 수용체에 대한 특이적 억제제
KR101535319B1 (ko) 2008-11-05 2015-07-10 유니버시티 오브 써던 캘리포니아 후생적 조절의 소형 분자 조절물질, 그리고 이들의 치료적 적용
US20130039998A1 (en) 2008-12-24 2013-02-14 University Of Washington Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorder
JP5246715B2 (ja) 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
UA103918C2 (en) 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
WO2011009826A2 (en) 2009-07-21 2011-01-27 ADAMED Sp.z o.o. Novel chalcone derivatives with cytotoxic activity
EP3915367A1 (en) 2010-08-18 2021-12-01 BioSplice Therapeutics, Inc. Diketones and hydroxyketones as catenin signaling pathway activators
KR101784940B1 (ko) 2010-08-31 2017-10-12 (주)아모레퍼시픽 피부 탄력 개선용 화장료 조성물
USRE47009E1 (en) 2011-02-01 2018-08-28 The Children's Hospital Of Philadelphia HDAC inhibitors and therapeutic methods using the same
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
US8871748B2 (en) * 2011-09-07 2014-10-28 Island Kinetics Inc. Retinal cyclodextrin acetals and hemiacetals for treating skin complexion disorder
US9668691B2 (en) 2011-09-22 2017-06-06 Lvmh Recherche Method to measure skin elasticity and firmness
EP2810198B1 (en) 2012-01-30 2023-07-12 Universiteit Gent Anti-invasive compounds
US20130302381A1 (en) 2012-05-09 2013-11-14 Cook Medical Technologies Llc Implantable Medical Devices Including a Water-Insoluble Therapeutic Agent
US8865700B2 (en) * 2012-12-20 2014-10-21 Avon Products, Inc. Collagen stimulators and their use in the treatment of skin
PE20151721A1 (es) 2013-02-22 2015-12-07 Samumed Llc Y-dicetonas como activadores de la ruta de senalizacion de wnt/b-catenina
EA027879B1 (ru) 2013-02-22 2017-09-29 Пфайзер Инк. ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-РОДСТВЕННЫХ КИНАЗ (JAK)
HRP20170607T1 (hr) 2013-02-22 2017-06-30 H. Lundbeck A/S Proizvodni postupak vortioksetina
ES2731681T3 (es) 2013-02-22 2019-11-18 Abbvie Stemcentrx Llc Conjugados de anticuerpo anti-DLL3 y PBD y usos de los mismos
DK3206686T3 (da) 2014-08-20 2019-12-16 Samumed Llc Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker

Also Published As

Publication number Publication date
HRP20192161T1 (hr) 2020-02-21
CN107106549A (zh) 2017-08-29
KR102165385B1 (ko) 2020-10-15
WO2016029021A1 (en) 2016-02-25
AU2015305373B2 (en) 2020-12-10
US9795550B2 (en) 2017-10-24
EP3206686A4 (en) 2018-04-11
MX2017002285A (es) 2018-01-23
RS59797B1 (sr) 2020-02-28
EP3206686A1 (en) 2017-08-23
US20220087917A1 (en) 2022-03-24
ES2762559T3 (es) 2020-05-25
PT3206686T (pt) 2020-01-06
RU2017108750A (ru) 2018-09-23
CA2958580A1 (en) 2016-02-25
US11839679B2 (en) 2023-12-12
LT3206686T (lt) 2020-01-10
US11077046B2 (en) 2021-08-03
EP3206686B1 (en) 2019-10-09
US10434052B2 (en) 2019-10-08
SI3206686T1 (sl) 2020-03-31
RU2017108750A3 (da) 2019-04-02
AU2015305373A1 (en) 2017-03-16
CA2958580C (en) 2023-10-24
JP2017525767A (ja) 2017-09-07
SMT201900709T1 (it) 2020-01-14
RU2727039C2 (ru) 2020-07-17
IL250663B (en) 2020-09-30
US20200222295A1 (en) 2020-07-16
IL250663A0 (en) 2017-04-30
CN107106549B (zh) 2020-06-16
BR112017003959A2 (pt) 2018-12-18
BR112017003959B1 (pt) 2022-08-02
US20180193244A1 (en) 2018-07-12
JP6766047B2 (ja) 2020-10-07
US20160206540A1 (en) 2016-07-21
CL2017000410A1 (es) 2017-10-30
CY1122603T1 (el) 2021-03-12
PL3206686T3 (pl) 2020-04-30
MA40454B1 (fr) 2020-01-31
HUE046741T2 (hu) 2020-03-30
KR20170066342A (ko) 2017-06-14
MX368248B (es) 2019-09-25
ZA201701460B (en) 2023-12-20

Similar Documents

Publication Publication Date Title
HUE046741T2 (hu) Gamma-diketonok bõröregedés és ráncok megelõzésére és kezelésére
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3149019T3 (da) Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3227262T3 (da) Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling
DK3259597T3 (da) Pvrig-polypeptider og fremgangsmåder til behandling
DK3757206T3 (da) Transduktionsfremgangsmåde og cellebehandling
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3212189T3 (da) Substituerede chromaner og fremgangsmåde til anvendelse deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3183010T3 (da) Anordning og tilhørende fremgangsmåde til behandling af medicinsk affald
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3178324T3 (da) Mikrobicid og fremgangsmåde til fremstilling af samme
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3191103T3 (da) Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
DK3691649T3 (da) Sammensætninger og fremgangsmåder til sårbehandling
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3185872T3 (da) Formulering af testosteron og metoder til behandling hermed